Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
5.34
-0.04 (-0.74%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Zepp Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 271.91 | 258.9 | 182.6 | 352.86 | 613.64 | 983.36 | |
Revenue Growth (YoY) | 50.07% | 41.78% | -48.25% | -42.50% | -37.60% | -0.15% |
Cost of Revenue | 151.77 | 159.71 | 112.37 | 260.5 | 494.78 | 777.93 |
Gross Profit | 104.27 | 99.19 | 70.23 | 92.36 | 118.86 | 205.42 |
Selling, General & Admin | 79.47 | 83.1 | 71.33 | 71.31 | 103.42 | 109.6 |
Research & Development | 44.56 | 45.32 | 46.16 | 51.5 | 77.3 | 81.04 |
Total Operating Expenses | 124.03 | 128.42 | 117.48 | 122.81 | 180.71 | 190.64 |
Operating Income | -28.55 | -29.23 | -47.25 | -30.45 | -61.86 | 14.78 |
Interest Income | 1.18 | 1.53 | 3.67 | 3.09 | 1.82 | 2.63 |
Interest Expense | -5.99 | -5.7 | -5.55 | -6.75 | -8.44 | -7.06 |
Other Non-Operating Income (Expense) | -1.87 | -4.13 | -12.99 | 0.6 | 15.27 | 12.89 |
Total Non-Operating Income (Expense) | -6.68 | -8.3 | -14.87 | -3.07 | 8.65 | 8.46 |
Pretax Income | -35.18 | -35.46 | -57.9 | -34.63 | -55.89 | 16.78 |
Provision for Income Taxes | 2.64 | 2.54 | 13.69 | -2.43 | -9.87 | 1.69 |
Net Income | -20.33 | -40.07 | -75.81 | -31.09 | -43.35 | 21.55 |
Minority Interest in Earnings | - | - | -0.08 | -0.07 | -0.1 | -0.13 |
Net Income to Common | -39.97 | -40.07 | -75.73 | -31.02 | -43.24 | 21.68 |
Net Income Growth | - | - | - | - | - | -38.08% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 15 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 15 | 15 | 17 |
Shares Change (YoY) | -0.40% | -1.72% | 6.47% | -1.28% | -6.84% | 1.54% |
EPS (Basic) | -2.72 | -2.56 | -4.64 | -2.08 | -2.88 | 1.38 |
EPS (Diluted) | -2.72 | -2.56 | -4.64 | -2.08 | -2.88 | 1.31 |
EPS Growth | - | - | - | - | - | -39.35% |
Free Cash Flow | - | -26.21 | -25.8 | 41.01 | -118.32 | -43.82 |
Free Cash Flow Per Share | - | -1.65 | -1.59 | 2.70 | -7.69 | -2.65 |
Gross Margin | 38.35% | 38.31% | 38.46% | 26.17% | 19.37% | 20.89% |
Operating Margin | -10.50% | -11.29% | -25.88% | -8.63% | -10.08% | 1.50% |
Profit Margin | -7.48% | -15.48% | -41.52% | -8.81% | -7.06% | 2.19% |
FCF Margin | - | -10.12% | -14.13% | 11.62% | -19.28% | -4.46% |
EBITDA | -28.55 | -24.7 | -42.23 | -22.76 | -53.15 | 22.94 |
EBITDA Margin | -10.50% | -9.54% | -23.13% | -6.45% | -8.66% | 2.33% |
EBIT | -28.55 | -29.23 | -47.25 | -30.45 | -61.86 | 14.78 |
EBIT Margin | -10.50% | -11.29% | -25.88% | -8.63% | -10.08% | 1.50% |
Effective Tax Rate | -7.51% | -7.15% | -23.65% | 7.02% | 17.65% | 10.07% |